AI
By
Could Everest Medicines’ AI-Powered mRNA Platform Signal a Turning Point for Cancer and Autoimmune Therapies in Asia?
Key Highlights Reimagining Cancer Vaccines with AI-Optimized PersonalizationAt the 2025 Everest Medicines R&D Day, the company showcased EVM16,…
Shift Bioscience Unveils AI Framework to Improve Gene Target Discovery for Rejuvenation Therapies
Key Highlights Deeper DiveCambridge-based Shift Bioscience is rethinking how AI models are evaluated for rejuvenation research. Their study,…
Is Ochsner Health’s AI Strategy a Blueprint for Ethical, Effective Physician Support?
Key Highlights Physicians Demand Responsible AIAn AMA survey of nearly 1,200 physicians revealed strong consensus on AI expectations:…
FDA clears Felix NeuroAI, the first AI-powered noninvasive wristband for essential tremor relief for 7 Million Patients
Key Takeaways FDA Clears First AI-Driven Wristband for Essential TremorFasikl’s Felix NeuroAI Wristband has received 510(k) clearance from…
How Will METiS Technologies’ RMB 400 Million Series D Raise Accelerate Beijing’s AI-Powered Nanodelivery Revolution in Biopharma by 2027?
Key Highlights Strong Capital Infusion to Accelerate AI-Driven Nanotechnology DevelopmentThe recent RMB 400 million (~$57 million) financing round…
How Will Lantern Pharma’s PredictBBB.ai Advance with 94% Accuracy Revolutionize CNS Drug Development?
Key Highlights Breakthrough AI Methodology Sets New Industry BenchmarkLantern’s proprietary ensemble of machine learning algorithms—including logistic regression, random…
